{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T20:43:02Z","timestamp":1761597782042},"reference-count":25,"publisher":"International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BST"],"published-print":{"date-parts":[[2017]]},"DOI":"10.5582\/bst.2016.01249","type":"journal-article","created":{"date-parts":[[2017,1,29]],"date-time":"2017-01-29T17:08:49Z","timestamp":1485709729000},"page":"105-109","source":"Crossref","is-referenced-by-count":6,"title":["Progress of research on microRNAs with diagnostic value in asbestos exposure: A call for method standardization"],"prefix":"10.5582","volume":"11","author":[{"given":"Luigina","family":"Micolucci","sequence":"first","affiliation":[{"name":"Computational Pathology Unit, Department of Clinical and Molecular Sciences, Universit\u00e0 Politecnica delle Marche"},{"name":"Laboratory of Experimental Pathology, Department of Clinical and Molecular Sciences, Universit\u00e0 Politecnica delle Marche"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Rita","family":"Rippo","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Pathology, Department of Clinical and Molecular Sciences, Universit\u00e0 Politecnica delle Marche"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiola","family":"Olivieri","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Pathology, Department of Clinical and Molecular Sciences, Universit\u00e0 Politecnica delle Marche"},{"name":"Center of Clinical Pathology and Innovative Therapy, Italian National Research Center on Aging (INRCA-IRCCS)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio Domenico","family":"Procopio","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Pathology, Department of Clinical and Molecular Sciences, Universit\u00e0 Politecnica delle Marche"},{"name":"Center of Clinical Pathology and Innovative Therapy, Italian National Research Center on Aging (INRCA-IRCCS)"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3542","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Frank AL, Joshi TK. The global spread of asbestos. Ann Glob Heal. 2014; 80:257-262.","DOI":"10.1016\/j.aogh.2014.09.016"},{"key":"2","unstructured":"2. IARC. Arsenic, metals, fibres, and dusts. IARC Monogr Eval Carcinog Risks Hum. 2012; 100:11-465."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Norbet C, Joseph A, Rossi SS, Bhalla S, Gutierrez FR. Asbestos-Related Lung Disease: A Pictorial Review. Curr Probl Diagn Radiol. 2015; 44:371-382.","DOI":"10.1067\/j.cpradiol.2014.10.002"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Delgermaa V, Takahashi K, Park E-K, Le GV, Hara T, Sorahan T. Global mesothelioma deaths reported to the World Health Organization between 1994 and 2008. Bull World Health Organ. 2011; 89:716-724.","DOI":"10.2471\/BLT.11.086678"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Yang H, Testa JR, Carbone M. Mesothelioma epidemiology, carcinogenesis, and pathogenesis. Curr Treat Options Oncol. 2008; 9:147-157.","DOI":"10.1007\/s11864-008-0067-z"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Husain AN, Colby T, Ordonez N, et al. Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med. 2013; 137:647-667.","DOI":"10.5858\/arpa.2012-0214-OA"},{"key":"7","unstructured":"7. Opitz I. Management of malignant pleural mesothelioma-The European experience. J Thorac Dis. 2014; 6:S238-252."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Greillier L, Baas P, Welch JJ, Hasan B, Passioukov A. Biomarkers for malignant pleural mesothelioma: Current status. Mol Diagn Ther. 2008; 12:375-390.","DOI":"10.1007\/BF03256303"},{"key":"9","unstructured":"9. Reid G. MicroRNAs in mesothelioma: From tumour suppressors and biomarkers to therapeutic targets. J Thorac Dis. 2015; 7:1031-1040."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Shen J, Stass SA, Jiang F. MicroRNAs as potential biomarkers in human solid tumors. Cancer Lett. 2013; 329:125-136.","DOI":"10.1016\/j.canlet.2012.11.001"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Nair VS, Pritchard CC, Tewari M, Ioannidis JPA. Design and Analysis for Studying microRNAs in Human Disease: A Primer on -Omic Technologies. Am J Epidemiol. 2014; 180:140-152.","DOI":"10.1093\/aje\/kwu135"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Turchinovich A, Weiz L, Langheinz A, Burwinkel B. Characterization of extracellular circulating microRNA. Nucleic Acids Res. 2011; 39:7223-7233.","DOI":"10.1093\/nar\/gkr254"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Arroyo JD, Chevillet JR, Kroh EM, Ruf IK, Pritchard CC, Gibson DF, Mitchell PS, Bennett CF, Pogosova-Agadjanyan EL, Stirewalt DL, Tait JF, Tewari M. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci U S A. 2011; 108:5003-5008.","DOI":"10.1073\/pnas.1019055108"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Vickers KC, Palmisano BT, Shoucri BM, Shamburek RD, Remaley AT. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol. 2011; 13:423-433.","DOI":"10.1038\/ncb2210"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Micolucci L, Akhtar MM, Olivieri F, Rippo MR, Procopio AD. Diagnostic value of microRNAs in asbestos exposure and malignant mesothelioma: systematic review and qualitative meta-analysis. Oncotarget. 2016; 7:58606-58637.","DOI":"10.18632\/oncotarget.9686"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Ogino S, Lochhead P, Giovannucci E, Meyerhardt JA, Fuchs CS, Chan AT. Discovery of colorectal cancer PIK3CA mutation as potential predictive biomarker: Power and promise of molecular pathological epidemiology. Oncogene. 2014; 33:2949-2955.","DOI":"10.1038\/onc.2013.244"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17. Hamada T, Keum N, Nishihara R, Ogino S. Molecular pathological epidemiology: new developing frontiers of big data science to study etiologies and pathogenesis. J Gastroenterol. 2016. doi: 10.1007\/s00535-016-1272-3.","DOI":"10.1007\/s00535-016-1272-3"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Ogino S, Chan AT, Fuchs CS, Giovannucci E. Molecular pathological epidemiology of colorectal neoplasia: An emerging transdisciplinary and interdisciplinary field. Gut. 2011; 60:397-411.","DOI":"10.1136\/gut.2010.217182"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Ogino S, Lochhead P, Chan AT, Nishihara R, Cho E, Wolpin BM, Meyerhardt JA, Meissner A, Schernhammer ES, Fuchs CS, Giovannucci E. Molecular pathological epidemiology of epigenetics: Emerging integrative science to analyze environment, host, and disease. Mod Pathol. 2013; 26:465-484.","DOI":"10.1038\/modpathol.2012.214"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. National Research Council (US) Committee on A Framework for Developing a New Taxonomy of Disease. Toward Precision Medicine. Building a Knowledge Network for Biomedical Research and a New Taxonomy of Disease. Washington (DC): National Academies Press (US); 2011. doi: 10.17226\/13284.","DOI":"10.17226\/13284"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Lu Y-F, Goldstein DB, Angrist M, Cavalleri G. Personalized Medicine and Human Genetic Diversity. Cold Spring Harb Perspect Med. 2014; 4:a008581.","DOI":"10.1101\/cshperspect.a008581"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Brockm\u00f6ller J, Tzvetkov M V. Pharmacogenetics: data, concepts and tools to improve drug discovery and drug treatment. Eur J Clin Pharmacol. 2008; 64:133-157.","DOI":"10.1007\/s00228-007-0424-z"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Byron SA, Van Keuren-Jensen KR, Engelthaler DM, Carpten JD, Craig DW. Translating RNA sequencing into clinical diagnostics: opportunities and challenges. Nat Rev Genet. 2016; 17:257-271.","DOI":"10.1038\/nrg.2016.10"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Poste G, Compton CC, Barker AD. The national biomarker development alliance: confronting the poor productivity of biomarker research and development. Expert Rev Mol Diagn. 2015; 15:211-218.","DOI":"10.1586\/14737159.2015.974561"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Barker AD, Compton CC, Poste G. The National Biomarker Development Alliance accelerating the translation of biomarkers to the clinic. Biomark Med. 2014; 8:873-876.","DOI":"10.2217\/bmm.14.52"}],"container-title":["BioScience Trends"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bst\/11\/1\/11_2016.01249\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T05:16:26Z","timestamp":1498367786000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bst\/11\/1\/11_2016.01249\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.5582\/bst.2016.01249","relation":{},"ISSN":["1881-7815","1881-7823"],"issn-type":[{"value":"1881-7815","type":"print"},{"value":"1881-7823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}